Related Experiment Video
Updated: Aug 12, 2026
09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Effects of alcohol on platelet functions
1INSERM, Unit 330, Bordeaux, France.
Summary
Moderate alcohol intake may protect against heart disease and stroke. However, binge drinking can increase clotting risk, a rebound effect not seen with moderate red wine consumption.
Area of Science:
- Cardiovascular Science
- Pharmacology
Background:
- Epidemiologic studies suggest moderate alcohol intake protects against coronary heart disease and ischemic stroke.
- Alcohol consumption may increase the risk of cerebral hemorrhage.
- Alcohol's effect on platelets resembles aspirin's, influencing aggregation responses.
Purpose of the Study:
- To investigate the immediate and delayed effects of alcohol on platelet aggregation.
- To explore the potential mechanisms behind alcohol's cardiovascular effects, including the 'rebound phenomenon'.
- To compare the effects of red wine and spirits on platelet function and lipid peroxidation.
Main Methods:
- In vitro and in vivo studies on human and animal platelet aggregation.
- Analysis of platelet aggregation in response to various agonists (thrombin, ADP, epinephrine, collagen).
- Assessment of lipid peroxidation markers (conjugated dienes) in relation to alcohol consumption.
Main Results:
- Alcohol acutely decreases platelet aggregation, but a rebound increase in aggregation, particularly to thrombin, occurs hours later or after withdrawal.
- This rebound phenomenon, observed in binge drinkers and alcoholics, may explain increased ischemic events.
- Moderate red wine consumption did not show the rebound effect; grape tannins in wine reduced lipid peroxidation, unlike spirits.
Conclusions:
- Alcohol's effect on platelet aggregation is complex, with potential risks associated with binge drinking due to a rebound hyper-aggregative state.
- Moderate red wine consumption may offer cardiovascular protection by mitigating alcohol-induced platelet rebound and reducing lipid peroxidation.
- Further research is needed to fully understand the role of lipid peroxides in alcohol-related platelet reactivity and cardiovascular outcomes.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.